Company
Funding data: Recent Funding. Each amount links to the announcement it came from.
Funding data: Recent Funding. Each amount links to the announcement it came from.
Mwyngil Therapeutics develops oral small-molecule therapies for metabolic, inflammatory, neuroinflammatory, and renal diseases.
| Date | Stage | Amount | Valuation | Investors | Source |
|---|